Health Care & Life Sciences » Biotechnology | Microbix Biosystems Inc.

Microbix Biosystems Inc.

Microbix Biosystems Inc.
Stock Exchange Other OTC
EPS
$0.06
Market Cap
$20.03 M
Shares Outstanding
96.77 M
Public Float
-
Microbix Biosystems Inc.
Stock Exchange Toronto Stock Exchange Prices
EPS
CAD0.08
Market Cap
CAD26.67 M
Shares Outstanding
96.97 M
Public Float
80.66 M

Profile

Address
265 Watline Avenue
Mississauga Ontario L4Z 1P3
Canada
Employees -
Website http://www.microbix.com
Updated 07/08/2019
Microbix Biosystems, Inc. engages in the manufacture of viral and bacterial antigens and reagents for the global diagnostics industry. Its biological solutions include products for human health applications in the vaccine, therapeutic and diagnostic markets, and a product for the worldwide animal reproduction market. Its pipeline of technologies and products include LumiSort, semen sexing technology for the livestock industries; and Kinlytic, a thrombolytic drug for life-threatening blood clots.

Financials

View All

William J. Gastle
Executive Chairman
Cameron L. Groome
President, Chief Executive Officer & Director